Free Trial

ANI Pharmaceuticals (ANIP) SEC Filings & 10K Form

$59.39
-1.35 (-2.22%)
(As of 06/20/2024 ET)

Recent ANI Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/20/2024
6:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:46 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
3:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:23 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:51 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
6:34 AM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
5:08 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
6:54 PM
ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:58 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:59 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:02 PM
ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:03 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:45 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:14 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:21 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:05 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
3:59 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
6:47 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
4:25 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:09 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
5:26 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:43 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:33 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:19 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
8:33 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:28 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:12 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:13 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
8:53 PM
ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2024
3:42 PM
ANI Pharmaceuticals (Filer)
Form ARS
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.
04/02/2024
5:59 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:17 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:09 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
6:30 AM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SC 13D/A
03/13/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:48 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
5:58 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:39 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:43 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:25 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
8:42 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:16 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:58 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:31 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:24 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:18 PM
ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:09 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:12 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:18 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:55 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:22 AM
ANI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
5:58 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:47 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:50 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:53 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:34 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:26 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:05 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
5:06 AM
ANI Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
02/08/2024
7:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
5:14 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
4:32 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:52 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
3:30 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
5:20 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
4:06 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2024
3:32 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2024
6:45 AM
ANI Pharmaceuticals (Subject)
Esjay LLC (Filed by)
Form SC 13D/A
01/16/2024
8:09 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:27 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:30 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
4:44 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:31 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.
12/18/2023
4:35 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
4:18 PM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SC 13D/A
12/15/2023
3:57 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
4:49 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:30 PM
ANI Pharmaceuticals (Subject)
Esjay LLC (Filed by)
Form SC 13D/A
11/20/2023
7:58 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4/A
11/20/2023
8:05 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
2:24 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
5:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ANIP) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners